|
|
Asymptomatic (N=8) |
Symptomatic (N=7) |
|
|
|
n (%) |
n (%) |
|
MMP-9 CD34 |
No expression |
3 (37.5) |
1 (14) |
0.273 |
|
1-25% |
0 (0) |
3 (43) |
|
|
26-50% |
0 (0) |
0 (0) |
|
|
51-75% |
2 (25) |
2 (29) |
|
|
>75% |
3 (37.5) |
1 (14) |
|
MMP-9 CD68 |
No expression |
0 (0) |
1 (14) |
0.014 |
|
Rare or 1 cluster >20 cells |
4 (50) |
0 (0) |
|
|
<5 clusters >20 cells |
2 (25) |
0 (0) |
|
|
>5 clusters >20 cells or 1
cluster>100 cells |
2 (25) |
6 (86) |
|
MMP-9 SMA |
No expression |
0 (0) |
1 (13) |
0.143 |
|
Rare or 1 cluster >20 cells |
6 (75) |
2 (29) |
|
|
<5 clusters >20 cells |
0 (0) |
2 (29) |
|
|
>5 clusters >20 cells or 1
cluster>100 cells |
2 (25) |
2 (29) |
|
MVD CD34 |
n, median (interquartile ranges) |
6 (2.5, 10.0; 2, 15) |
17
(6, 23; 1, 34) |
0.0642
|
lipid core/TPA |
<10% |
0 (0) |
0 (0) |
0.132 |
|
10-40% |
6 (75) |
2 (29) |
|
|
>40% |
2 (25) |
5 (71) |
|
SMA cells |
Low density and no circumference |
6 (75) |
2 (29) |
0.132 |
|
High density and 100% circumference |
2 (25) |
5 (71) |
|
CD68 cells |
Low density |
2 (25) |
1 (14) |
1.000 |
|
High density |
6 (75) |
6 (86) |
|